Effect of sustained release alprenolol in hypertension uncontrolled by chlorothiazide and dihydralazine. Study in double blind
Cartier, F.; Merot, M.L.
La Semaine des Hopitaux Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 54(25-28): 855-857
1978
ISSN/ISBN: 0037-1777 PMID: 214866 Document Number: 128493
In 20 hypertensive patients with functioning renal graft, sustained release alprenolol or placebo was given orally for 2 months, in combination with chlorothiazide and dihydralazine, after previous failure of these 2 last drugs. Blood pressure was normalized with alprenolol during the length of the study, but is was not with placebo. Mean plasma renine level decreased of 45 p. cent.
Document emailed within 1 workday
Related Documents
Hanák, T. 1977: Double-blind cross-over study with alprenolol and diazepam in the treatment of functional sympathicotonic cardiovascular diseases Die Medizinische Welt 28(51-52): 2071Hart, W.L.; Parmley, L.F. 1978: The effect of lorazepam on hypertension-associated anxiety: a double-blind study Journal of Clinical Psychiatry 39(10 Part 2): 41-45
Iversen, O.; Fowles, M.; Vlieg, M.; Smidt, N.; Wigley, R. 1981: Sustained release indomethacin: a double blind comparison with indomethacin suppositories New Zealand Medical Journal 93(682): 261-262
Thienthong, S.; Krisanaprakornkit, W.; Taesiri, W.; Thaninsurat, N.; Utsahapanich, S.; Klaichanad, C. 2004: Two doses of oral sustained-release tramadol do not reduce pain or morphine consumption after modified radical mastectomy: a randomized, double blind, placebo-controlled trial Journal of the Medical Association of Thailand 87(1): 24-32
Fromantin, M. 1979: Effect and tolerance of Phanurane in the treatment of essential hypertension. (Double blind study) La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(41-42): 1965-1967
Mastropasqua, F.; Totaro, P.; Massari, F.; Pitzalis, M.V.; Rizzon, P. 1998: Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms Cardiologia 43(6): 617-623
Zhao, S.; Wang, F.; Yang, K.; Hao, Y.; Li, G.; Yang, M.; Yang, Z. 2014: Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study Zhonghua Nei Ke Za Zhi 53(6): 455-459
Lorentzen, F.; Jorgensen, P.; Nielsen, E.; Nyberg, G.; Hvidt, S. 1973: Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris Ugeskrift for Laeger 135(27): 1431-1438
Harrewyn, J.M.; Amor, B. 1983: Double-blind comparative study of slow-release ketoprofen and a placebo in chronic inflammatory rheumatism La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(46): 3225-3228
Rampon, S. 1983: Double-blind comparative study of slow-release ketoprofen tablets and indomethacin in coxarthrosis and gonarthrosis La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(46): 3243-3245
Gougeon, J. 1983: Comparative double-blind study of ketoprofen slow-release tablets and indomethacin in coxarthrosis and gonarthrosis La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(46): 3246-3248
Hua, A.S.; Kalowski, S.; Whitworth, J.A.; Kincaid-Smith, P. 1980: Acebutolol in mild to moderate hypertension: a double-blind crossover study Medical Journal of Australia 1(5): 226-228
Guevara, J.; Sukerman, M.; Velasco, M. 1975: A randomized double-blind study of timolol in patients with essential hypertension Current Therapeutic Research 18(4): 534-538
Weiss, G.; Klemm, F.H.; Fuchs, W.S.; Stanislaus, F.; Zema, M.; Calanchi, M. 1998: Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension Arzneimittel-Forschung 48(5a): 604-612
Angelino, P.F.; Alvino-Demartino, A.; Mappa, R.; Donati, C. 1985: Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 23(9): 501-505
Eiskjaer, H.; Pedersen, E.B.; Rasmussen, L.M.; Jespersen, B. 1989: Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins Journal of Cardiovascular Pharmacology 13 Suppl. 4: S17-S22
Nechwatal, W. 1987: Doxazosin and nitrendipine. a double-blind comparative study in patients with mild to moderate hypertension Fortschritte der Medizin 105(34): 679-682
Barnett, A.J.; Kalowski, S.; Guest, C. 1978: Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study Medical Journal of Australia 1(2): 105-109
Cernohorský, D.; Král, B.; Hamet, A.; Eliás, J.; Tilser, P.; Rozánek, P.; Sramar, V.; Koudelka, V. 1986: Effect of dihydralazine Spofa on precapillary pulmonary hypertension Vnitrni Lekarstvi 32(9): 855-861
Hosie, J.; Nasar, M.A.; Belgrave, G.P.; Walters, E.G. 1994: A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension Acta Cardiologica 49(3): 251-265